Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAD-dependent oxidoreductase domain-containing protein 1 (FOXRED1) is a mitochondrial enzyme and molecular chaperone involved in the assembly and stabilization of respiratory chain complex I (NADH:ubiquinone oxidoreductase), the first and largest enzyme of the electron transport chain[3][5][6][8]. FOXRED1 contains a FAD-binding oxidoreductase domain, is encoded by the nuclear genome, and is evolutionarily related to the d-amino acid oxidase family[5]. Its primary function is to promote the assembly and integrity of complex I during mid-to-late stages, a critical step in mitochondrial bioenergetics, redox balance, and ATP production[2][3][5][7]. Loss-of-function mutations in FOXRED1 cause complex I deficiency, leading to severe mitochondrial diseases, including Leigh syndrome, encephalopathy with lactic acidosis, cardiomyopathy, and other multisystemic phenotypes with variable severity and poor prognosis[4][7][8]. FOXRED1 dysfunction may also alter cellular oxidative stress responses and influence disease outcomes in certain cancers[5]. There are currently no known direct drugs targeting FOXRED1, but its essential role in mitochondrial function makes it a potential target for therapeutic intervention and a biomarker for complex I-related disorders.
Restoration of complex I assembly or stabilization (inferred for potential therapeutic strategies targeting FOXRED1 dysfunction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAD-dependent oxidoreductase domain-containing protein 1 (FOXRED1).